BSE filing, NSE: WINDLAS. Summary written from the filing by ALFA Finder's alert engine.
Windlas Biotech Ltd: key numbers
- Share price
- ₹923.40
- Market cap
- ₹1,938 Cr
- Revenue (annual)
- ₹904.1 Cr
- Net profit (annual)
- ₹66.44 Cr
- P/E (TTM)
- 29.2×Sector 48.7×
- Promoter holding
- 63.31%+0.00% QoQ
- FII holding
- 2.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Windlas Biotech Ltd
All →Windlas Biotech Other Announcement
This quarterly shareholding pattern statement for Windlas Biotech Ltd, covering the period ended September 30, 2026, provides the company's equity ownership breakdown.
Windlas Biotech Management Change
Windlas Biotech appointed Aashish Mehra and Soni Saran Singh as Independent Directors. Vivek Dhariwal resigned as Independent Director and Chairman of the Board.
Windlas Biotech Earnings Call Transcript: Key Takeaways
Windlas Biotech reported record quarterly revenue driven by 29% growth in CDMO vertical. Management focuses on operational excellence and capacity expansion via Plant 6 commercialization.
Windlas Biotech Results Update
Windlas Biotech reported Q1 FY27 revenue of Rs 248 crore, an 18% YoY growth. The release highlights an adjusted EBITDA of Rs 34 crore and PAT of Rs 25 crore.
Windlas Biotech Investor Presentation: Key Takeaways
Windlas Biotech reported Q1FY27 revenue of ₹248 Cr (18% YoY). Adjusted EBITDA and PAT grew 26% and 37% respectively, excluding ESOP costs, driven by CDMO expansion.
Windlas Biotech Q1 FY27 Results: Net Profit ₹17.7 Cr, Up 0.0% YoY
Windlas Biotech Ltd reported revenue from operations of ₹248.1 Cr (+18.1% YoY) and net profit of ₹17.7 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹17.7 Cr · +0.0% YoY
Other board meeting date announcements
All →Urja Global Board Meeting Date
Urja Global Ltd has scheduled a Board Meeting on 5 Nov 2026 to approve unaudited financial results for Q2 and H1 FY27. The trading window is closed from 1 Oct 2026 until 48 hours after results declaration.
Meera Industries Board Meeting Date
Meera Industries will hold a board meeting on 6 Nov 2026 to approve Q1 FY27 unaudited results. No financial figures or material decisions are disclosed in this advance notice.
Utssav CZ Gold Jewels Board Meeting Date
Utssav CZ Gold Jewels scheduled a board meeting for 5 November 2026 to approve unaudited half-yearly results. No financial figures or decisions are reported in this advance intimation.
Coastal Corporation Board Meeting Date
Coastal Corporation Ltd intimated its Board meeting scheduled for 14 November 2026. The meeting will consider un-audited results for the half-year and Q2 ended 30 September 2026.
Veerhealth Care Board Meeting Date
Veerhealth Care Ltd will hold its Board meeting on 14 Nov 2026 to consider Q2 and H1 unaudited results. The trading window reopens on 17 Nov 2026.
Integrated Capital Services Board Meeting Date
Integrated Capital Services preponed its Board and Audit Committee meetings from Nov 14 to Nov 13, 2026. The rescheduling is due to festive season weekend inconvenience.